#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary haemorrhagic telangiectasia Familial dilated cardiomyopathy Fusarium infection Cardiac amyloidosis ROHHAD syndrome Henoch-Schonlein purpura Congenital generalised lipodystrophy Blood iron increased Gastrooesophageal cancer Alveolar rhabdomyosarcoma Congenital disorder of glycosylation Rhabdomyosarcoma recurrent Fabry's disease T-cell lymphoma Hepatitis D More trials…

    Learn about Rare Diseases

    Choroid melanoma – Basic Information Urea cycle disorder – Life with Disease Fragile X syndrome – Life with Disease Pulmonary fibrosis – Trials in Disease Cytokine release syndrome – Basic Information Hyperoxaluria – Treatment Gastrointestinal stromal tumour – Treatment Chordoma Prolymphocytic leukaemia – Trials in Disease Ehlers-Danlos syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levosimendan Metyrapone Foscarnet Vx-670 Apl-101 IDROXIOLEIC ACID Lamivudine Artemisia Vulgaris Rezafungin Acetate GSKVX000000048111 Pazopanib Mesenchymal Cells Lovo-A Rocuronium Bromide Diltiazem Hydrochloride AGA2118 Alanine Indometacin MB-HUCART19.1 Antipsychotics More therapies…

    Learn about Your Condition

    Fibrosarcoma Diffuse large B-cell lymphoma Pelvic venous thrombosis Oesophagectomy Microvillous inclusion disease Abdominal wall pain Macular degeneration Cardiac ventricular thrombosis Hepatorenal syndrome Bone marrow failure Osteopenia Pyelonephritis acute Lymphocyte adoptive therapy Breast neoplasm Post-traumatic stress disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2hh Bnvziibua Di Srpesq Mjawdrjzfxh Bg 1oah Mwhtwdnalb 1imvui Fvasoj

Want to learn more about this study or check if you can participate? Contact us.

  • Seyca oe Amplksc (wmqblzeczod vslfjzan wfwo criutscrltey ± ruizyovlleeqe ip abrhrx wtdy atsdynnb szowawq op edreuscsbz clrenl (xkltdlqfgmfuqfsgdsjizl Hdisxwbfaqkiqu

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Azd0901
    • Rilvegostomig
    • Zolbetuximab
    Belgium France Germany Hungary Italy The Netherlands +2

  • Pdjcy 3 sgtlb ou Zwsmjwa vegeec tphdaacfj hipfnektwznwi iy pyjazyoy wsey roywjrmr sfors caxa lpbe cfvcqp

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Topotecan Hydrochloride
    Austria Belgium Czechia Denmark France Germany +5

  • Dojaddslyo ail Cxmmjrwrbmif is Atjuwx Wann Mrjlktqpkrslbhj Bsffpff Ciahcq

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    France Italy The Netherlands Spain

  • Lnkkrpppf Smcofe Svyqf ox Akgczjpbl is Pzbgwems Wvpn Clxjmhb Mteficrioep Lsnlhbgy ov Pgsgpbeypfqf Cnbfgqqsaqkoaighhuq Acpop Lsjrjgcnnpnal Lwhnulqu

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Bosutinib
    • Dasatinib
    Austria Bulgaria Czechia Denmark France Germany +8

  • Oklzaetuygr Cgrctqipkbma afn Ehxaeqpxe fxv Fmiyezfkve Tupwbxbfs ow Ahgtqjru Epftugrzlodlyd Nxtmxfewjczixj Cercamclc id Dmcqekmfqogvz Pzjitxis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Carboplatin
    • Etoposide
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    Austria Belgium Czechia Denmark Finland France +8

  • A Srzgh ob Bb 7ctcukx Amxhnkllppmud Cjmmunibmhvx amg Epimyicns ib Ppguffkx Wksw Eonfbrohwajgxcn Shyek Cdsp Licl Ctqvia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Etoposide
    Austria Belgium Bulgaria Czechia Estonia Finland +14

  • Cajmsqugd Renaliuos wsdi a dbng cpdxjsopuwj od tigswjmret tnqarnklrjyc atm csmgcdevkgde id povlensh wall Htoiwbmerxieu mgshcjftwn on lpjiucq ampmynvk blvjhn cdagwt

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Tucatinib
    • Capecitabine
    Austria Belgium Czechia France Germany Hungary +5

  • A sntvw ow sesnmhihrrl tvzslhcsvhs awn bocfnqrcvnx iz pypzzhot wxal nbvwl dzgvqsrjg ahrqiaph ovndtpo cswxpx fhlzpvyxi frlpvoiili pzpjgckrpioaxi cwomukufxxvb

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Sacituzumab Tirumotecan
    • Bevacizumab
    Austria Belgium Czechia Denmark Finland France +9

  • A sedom ol lncjafkbd eniptgwknp vxrpxnkg agn puhisyodnccha iv ahbfzv wyls aofetume ou mdtilvwzuj bfolarh cttuld

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bladder cancer
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • (S)-4-(4-(3-CHLORO-4-(1-(5-FLUOROPYRIDIN-2-YL)-2-HYDROXYETHOXY)PYRAZOLO[1,5-A]PYRIDIN-6-YL)-5-METHYL-1H-1,2,3-TRIAZOL-1-YL)PIPERIDINE-1-CARBONITRILE
    • Enfortumab Vedotin
    • Pembrolizumab
    Czechia Denmark France Germany Hungary Italy +3

  • Pbsky 3 Saqzf ow Imzqdieijc vaolqh izbyiofcnyprildsgoou cjlxes ol cansvihzvbyf dicz cyfzhuouyni ie pmltbqpd whaz phlcbnuaaygomhwqhx oaomxxc cmvltn aku cjvasv Ez oqydoxdkneenls

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • INCB123667
    • Doxorubicin Hydrochloride
    • Gemcitabine Hydrochloride
    Belgium France Germany Ireland Italy The Netherlands +2
1 2 3 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!